Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indian Immunologicals to lead research collaboration to develop vaccine for COVID-19
The company will carry the research in collaboration with Griffith University, Australia
DGFT lifts export restriction on 12 molecules; paracetamol, HCQ on license basis
Ritonavir and Lopinavir will remain on the restricted list
Over 280 units in SEZs operational to manufacture pharmaceuticals, hospital devices
Besides, more than 1,900 IT and IT-enable service units have been facilitated to enable their employees to work from home
55 firms producing up to 70,000 litres of sanitiser per day in UP
There has been a spurt in the demand for sanitisers following the outbreak of coronavirus in the state and to deal with this, the…
NPPA revises ceiling price of scheduled formulations
Increase in ceiling price is based on Wholesale Price Index (WPI) which is 1.88468 percent
J&K sets up PMRU of NPPA to battle COVID-19
PMRUs have already been set up by NPPA in 11 States, including, Kerala, Odisha, Gujarat, Rajasthan, Punjab, Haryana, Nagaland,…
China’s recovery from COVID-19 should not tempt us to take the easy way out again
One silver lining of the COVID-19 infection is that policy decisions have been fast tracked
Indian Pharma sector seeks six months LC extension from RBI
Pharmexcil has requested the RBI to consider giving an extension of six months for due payments against non fund limits through…
IPA suggests best practices for employee safety in pharma manufacturing during COVID-1
The document echoes general insights on preventative measures and provides a comprehensive set of best practices for the safety of…
Lupin launches Mycophenolic Acid Delayed-Release Tablets USP
Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg, is the generic equivalent of Myfortic Delayed-Release Tablets,…